Please use this identifier to cite or link to this item:
http://hdl.handle.net/11189/7344
Title: | Potentials of Phytotherapeutic Treatment of Erectile Dysfunction | Other Titles: | Antioxidant-Antidiabetic Agents and Human Health | Authors: | Aboua, Yapo Guillaume Manirafasha, Claudine Mosito, Boitumelo R. Van der Linde, Michelle Du Plessis, Stefan Stephanus |
Keywords: | Phytotherapeutic Treatment;erectile dysfunction;libido;diabetes;chronic kidney disease | Issue Date: | 2014 | Publisher: | INTEC Open Science | Source: | Aboua, G., Manirafasha, C., Mosito, B. R. et al. 2014. Potentials of Phytotherapeutic Treatment of Erectile Dysfunction. (In: Antioxidant-Antidiabetic Agents and Human Health, Oluwafemi Oguntibeju, IntechOpen, [http://doi.org/10.5772/57174] | Abstract: | Erectile dysfunction (ED) or (male) impotence is a sexual dysfunction characterized by the inability to develop or maintain an erection of the penis [1]. There are various underlying causes, such as a compromised cardiovascular system and diseases such as diabetes and chronic kidney disease (CKD), many of which are medically treatable. The causes of erectile dysfunction may be physiological or psychological [2]. Sexual function includes libido, penile erection, ejaculation, and orgasm. While each of these parameters may be of concern to an individual patient, the vast majority of men complain of ED. Testosterone deficiency frequently is associated with decreased libido and ED. ED is a clinical problem that is underdiagnosed, under-evaluated, and under-treated. The prevalence of ED increases with age, and it is associated with multiple medical conditions including diabetes, hypertension, and heart disease that also increase with age. ED is a highly prevalent and often underreported condition. The prevalence of ED varies in different countries and approximately 100 million men worldwide are estimated to be affected with ED. More than half of US men between the ages of 40 and 70 years are estimated to have ED. The worldwide ED prevalence in men with diabetes ranges from 27% to 75% and it is estimated that the prevalence of ED will double in the next 25 years [3]. There is a strong link between ED and atherosclerotic disease due to the fact that they share similar risk factors. In a study where patients referred for myocardial perfusion single-photon emission computed tomography were screened for ED with a questionnaire, it was found out that 54.8% of the patients had ED. Patients with ED showed more severe coronary heart disease. In diabetic patients, ED has been shown to predict silent coronary artery disease, and in asymptomatic men without cardiovascular risk factors or | URI: | http://hdl.handle.net/11189/7344 | ISBN: | 978-953-51-1215-0 | DOI: | http://doi.org/10.5772/57174 |
Appears in Collections: | HWSci - Books / Book Chapters |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Potentials of Phytotherapeutic Treatment.pdf | 356.09 kB | Adobe PDF | View/Open |
Page view(s)
18
checked on Feb 9, 2021
Download(s)
10
checked on Feb 9, 2021
Google ScholarTM
Check
Altmetric
Items in Digital Knowledge are protected by copyright, with all rights reserved, unless otherwise indicated.